Opening new pathways for bioprocessing

A pivotal link between industry and academia, Teesside University’s £22m National Horizons Centre (NHC) opened last September with two very clear objectives. One is to drive research into bioprocessing, an often-overlooked subject through which life...

Firms call for major R&I investment to tackle environmental crises

Major investment into research and innovation (R&I) is needed to enable UK businesses to address the global biodiversity and climate crises, according to a new report. The report by the Valuing Nature Programme --– which...

Discovery raises possibility of asthma treatment

A University of Dundee researcher has uncovered why parasitic worm infections seem to protect people from developing asthma, paving the way for potential future treatments for the disease. Although it has been known for some...

Nemera takes dermal treatments to millions of patients

Nemera is a world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, including complex dermal drug delivery devices. Dermal pharmaceuticals, cosmetics and personal hygiene products all...

Find out why County Durham’s NETPark is quickly becoming a global hub for bio-science...

Home to two UK catapult centres, three national innovation centres and one of the country’s leading AIM listed tech companies, The North East Technology Park (NETPark) really is a thriving hub of innovation making...

BIOQUELL HELPING PHARMACEUTICAL COMPANIES RESUME OPERATIONS POST-COVID-19

Bioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity As the world prepares to enter the next phase of the COVID-19 pandemic with the potential...

anti-cancer compound discovered in the humble willow

Scientists led from Rothamsted Research, working with cancer biologists at the University of Kent have discovered the chemical, miyabeacin, which has been found to kill various cancer cells, including those resistant to other drugs. Of...

Switching on a key gene could provide first curative treatment for heart disease

Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell...

Sellafield research uncovers microbial life in fuel ponds

Two new research papers from The University of Manchester, working with colleagues at Sellafield Limited and the National Nuclear Laboratory show that microbes can actively colonise some of the most intensively radioactive waste storage...

Directing’ evolution to identify potential drugs earlier in discovery

Scientists have developed a technique that could significantly reduce the time to discover potential new antibody-based drugs to treat disease. Antibodies are produced by the body in response to the presence of a disease-causing agent....

Nemera and Noble announce collaboration to support patients who self-administer medication

 Nemera is excited to leverage the new collaboration to expand end-to-end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices  Nemera, world leader in design, development and manufacturing of drug...

UCL supports worldwide dissemination of free-to-access manufacturing instructions for COVID-19 breathing aids

Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design and manufacturing files of a breathing aid developed by UCL, UCLH and Mercedes-AMG High...

The impact of COVID-19 on innovation

The impact of COVID-19 on innovation by Nicholas Ferrar, partner and patent attorney AdamsonJones Times of crisis are sometimes accompanied by huge spikes in innovation. Much like a fight-or-flight response in individuals, a knee-jerk reaction to adverse...

FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE™ To Address Supply Bottlenecks In Gene...

Capabilities expand to supplying plasmids for triple transfections BILLINGHAM, United Kingdom, April 23, 2020 /PRNewswire/ -- FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the...

IBM releases novel AI-powered technology to accelerate medical research for COVID-19

IBM has today released a new set of cloud- and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery. These novel resources, from across IBM and available beginning today (Friday 3 April)...

Keeping Cool in a Global Pandemic

By Sonia Houghton, CEO, Cryosphere As Covid-19 spreads across the globe and governments worldwide are desperately trying to heed learnings from how China, Italy and other countries have managed the containment of the virus, the...